Enox Biopharma Inc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$230K

12 transactions

Summary

Enox Biopharma Inc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $230KSales: —4 insiders

Date	Insider	Type	Value
2010-11-04	David Itamar(Chief Financial Officer)	Buy	$60K
2010-07-15	David Itamar(Chief Financial Officer)	Buy	$60K
2010-08-12	Avniel Amir(Chairman of the Board)	Buy	$50K
2010-08-12	David Itamar(Chief Financial Officer)	Buy	$50K
2009-11-02	Av-Gay Yossef(President)	Buy	$10K
2011-01-01	Rewcastle John Cameron(Chief Executive Officer)	Buy	$0
2010-08-12	Avniel Amir(Chairman of the Board)	Buy	$0
2010-08-12	David Itamar(Chief Financial Officer)	Buy	$0
2010-03-01	Avniel Amir(Chairman of the Board)	A	$0
2010-03-01	Avniel Amir(Chairman of the Board)	A	$0
2010-02-15	David Itamar(Chief Financial Officer)	A	$0
2010-02-01	Av-Gay Yossef(CEO, President)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Enox Biopharma Inc — Contributions, Lobbying & Contracts | Poliscope